Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.6, 2002-06, pp. : 777-788

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Bivalirudin in Acute Coronary Syndromes

Current Pharmaceutical Design, Vol. 14, Iss. 12, 2008-04 ,pp. : 1191-1196

Bentham Science Publishers

Access to resources Recommend Favorite

Bivalirudin: A Pharmacoeconomic Profile of its Use in Patients with Acute Coronary Syndromes

By Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 343-359

Adis International

Access to resources Recommend Favorite

Bivalirudin: In Patients with Acute Coronary Syndromes Planned for Urgent or Early Intervention

By Deeks Emma D. Curran Monique P.

Drugs, Vol. 68, Iss. 16, 2008-01 ,pp. : 2345-2356

Adis International

Access to resources Recommend Favorite

Bivalirudin: A Review of its Potential Place in the Management of Acute Coronary Syndromes

By Carswell C.I. Plosker G.L.

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 841-870

Adis International

Access to resources Recommend Favorite

Fondaparinux in acute coronary syndromes

By Chaturvedi Vivek Karthikeyan Ganesan

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1615-1623

Informa Healthcare

Access to resources Recommend Favorite